Gut microbiome in multiple sclerosis: The players involved and the roles they play

Gut Microbes

Volumn 8, Issue 6, 2017, Pages 607-615

  Shahi, Shailesh K ^a   Freedman, Samantha N ^a   Mangalam, Ashutosh K ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Gut microbiome; Hostmicrobe interaction; Immune response; Microbial metabolism; Multiple sclerosis (MS); Phytoestrogen; Short chain fatty acids

Indexed keywords

INTERLEUKIN 10; RNA 16S; TRANSCRIPTION FACTOR FOXP3;

ACTINOBACTERIA; ALLERGIC ENCEPHALOMYELITIS; ARTICLE; BACTERIUM; BACTEROIDETES; BLAUTIA; CD4+ T LYMPHOCYTE; CLOSTRIDIUM; DOREA; DYSBIOSIS; FIRMICUTES; FUSOBACTERIUM; GENE SEQUENCE; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INTESTINE FLORA; MULTIPLE SCLEROSIS; MYCOPLANA; NONHUMAN; PARABACTEROIDES; POLYMERASE CHAIN REACTION; PREVOTELLA; PSEUDOMONAS; CLASSIFICATION; IMMUNOLOGY; MICROBIOLOGY;

BACTERIA; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; HOMEOSTASIS; HUMANS; MULTIPLE SCLEROSIS;

EID: 85026859563     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.1080/19490976.2017.1349041     Document Type: Article

References (37)

1. Chen J, Chia N, Kalari KR, Yao JZ, Novotna M, Soldan MM, et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep 2016; 6:28484; PMID:27346372; https://doi.org/10.1038/srep28484
2. Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R, Patel B, Mazzola MA, Liu S, Glanz BL, et al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun 2016; 7:12015; PMID:27352007; https://doi.org/10.1038/ncomms12015
3. Miyake S, Kim S, Suda W, Oshima K, Nakamura M, Matsuoka T, Chihara N, Tomita A, Sato W, Kim SW, et al. Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters. PLoS One 2015; 10:e0137429; PMID:26367776; https://doi.org/10.1371/journal.pone.0137429
4. Rothhammer V, Quintana FJ. Environmental control of autoimmune inflammation in the central nervous system. Curr Opin Immunol 2016; 43:46-53; PMID:27710839; https://doi.org/10.1016/j.coi.2016.09.002
5. Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain Behav Immun 2014; 38:1-12; PMID:24370461; https://doi.org/10.1016/j.bbi.2013.12.015
6. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005; 307:1915-20; PMID:15790844; https://doi.org/10.1126/science.1104816
7. Kinross JM, Darzi AW, Nicholson JK. Gut microbiomehost interactions in health and disease. Genome Med 2011; 3:14; PMID:21392406; https://doi.org/10.1186/gm228
8. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489:220-30; PMID:22972295; https://doi.org/10.1038/nature11550
9. Rescigno M. The intestinal epithelial barrier in the control of homeostasis and immunity. Trends Immunol 2011; 32:256-64; PMID:21565554; https://doi.org/10.1016/j.it.2011.04.003
10. Zhang K, Hornef MW, Dupont A. The intestinal epithelium as guardian of gut barrier integrity. Cell Microbiol 2015; 17:1561-9; PMID:26294173; https://doi.org/10.1111/cmi.12501
11. Blacher E, Levy M, Tatirovsky E, Elinav E. Microbiome-Modulated Metabolites at the Interface of Host Immunity. J Immunol 2017; 198:572-80; PMID:28069752; https://doi.org/10.4049/jimmunol.1601247
12. Jarchum I, Pamer EG. Regulation of innate and adaptive immunity by the commensal microbiota. Curr Opin Immunol 2011; 23:353-60; PMID:21466955; https://doi.org/10.1016/j.coi.2011.03.001
13. Branton WG, Lu JQ, Surette MG, Holt RA, Lind J, Laman JD, Power C. Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis. Sci Rep 2016; 6:37344; PMID:27892518; https://doi.org/10.1038/srep37344
14. Cantarel BL, Waubant E, Chehoud C, Kuczynski J, DeSantis TZ, Warrington J, Venkatesan A, Fraser CM, Mowry EM. Gut microbiota in multiple sclerosis: possible influence of immunomodulators. J Investig Med 2015; 63:729-34; PMID:25775034; https://doi.org/10.1097/JIM.0000000000000192
15. Castillo Álvarez F, Pérez Matute P, Colina Lizuain S, Erdocia Goñi A, Iglesias Gutiérrez Cecchini C, Gómez Eguilaz M, et al. Intestinal microbiota in multiple sclerosis: influence of treatment with interferon b-1b. European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). London, UK: ECTRIMS Online Library, 2016:146290.
16. Cekanaviciute E, Debelius JW, Singh S, Runia T, Nelson C, Yoo B, et al. Gut dysbiosis is a feature of MS and it is characterized by bacteria able to regulate lymphocyte differentiation in vitro. 2016 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). London, 2016:147026.
17. Tremlett H, Fadrosh DW, Faruqi AA, Hart J, Roalstad S, Graves J, Lynch S, Waubant E, US Network of Pediatric MS Centers. Gut microbiota composition and relapse risk in pediatric MS: A pilot study. J Neurol Sci 2016; 363:153-7; PMID:27000242; https://doi.org/10.1016/j.jns.2016.02.042
18. Tremlett H, Fadrosh DW, Faruqi AA, Hart J, Roalstad S, Graves J, Spencer CM, Lynch SV, Zamvil SS, Waubant E, et al. Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls. BMC Neurol 2016; 16:182; PMID:27652609; https://doi.org/10.1186/s12883-016-0703-3
19. Tremlett H, Fadrosh DW, Faruqi AA, Zhu F, Hart J, Roalstad S, Graves J, Lynch S, Waubant E, US Network of Pediatric MS Centers. Gut microbiota in early pediatric multiple sclerosis: a case-control study. Eur J Neurol 2016; 23:1308-21; PMID:27176462; https://doi.org/10.1111/ene.13026
20. Human Microbiome Project C. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486:207-14; PMID:22699609; https://doi.org/10.1038/nature11234
21. Cai L, Ye L, Tong AH, Lok S, Zhang T. Biased diversity metrics revealed by bacterial 16S pyrotags derived from different primer sets. PLoS One 2013; 8:e53649; PMID:23341963; https://doi.org/10.1371/journal. pone.0053649
22. Kuczynski J, Lauber CL, Walters WA, Parfrey LW, Clemente JC, Gevers D, Knight R. Experimental andanalytical tools for studying the human microbiome. Nat Rev Genet 2011; 13:47-58; PMID:22179717; https://doi.org/10.1038/nrg3129
23. Rajilic-Stojanovic M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, de Vos WM. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011; 141:1792-801; PMID:21820992; https://doi.org/10.1053/j.gastro.2011.07.043
24. Mukhopadhya I, Hansen R, El-Omar EM, Hold GL. IBD what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol 2012; 9:219-30; PMID:22349170; https://doi.org/10.1038/nrgastro.2012.14
25. Chung H, Kasper DL. Microbiota-stimulated immune mechanisms to maintain gut homeostasis. Curr Opin Immunol 2010; 22:455-60; PMID:20656465; https://doi.org/10.1016/j.coi.2010.06.008
26. Shapiro H, Thaiss CA, Levy M, Elinav E. The cross talk between microbiota and the immune system: metabolites take center stage. Curr Opin Immunol 2014; 30:54-62; PMID:25064714; https://doi.org/10.1016/j.coi.2014.07.003
27. Rios-Covian D, Ruas-Madiedo P, Margolles A, Gueimonde M, de Los Reyes-Gavilan CG, Salazar N. Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health. Front Microbiol 2016; 7:185; PMID:26925050; https://doi.org/10.3389/fmicb.2016.00 185
28. El Kaoutari A, Armougom F, Gordon JI, Raoult D, Henrissat B. The abundance and variety of carbohydrateactive enzymes in the human gut microbiota. Nat Rev Microbiol 2013; 11:497-504; PMID:23748339; https://doi.org/10.1038/nrmicro3050
29. Sivieri K, Morales ML, Adorno MA, Sakamoto IK, Saad SM, Rossi EA. Lactobacillus acidophilus CRL 1014 improved "gut health" in the SHIME reactor. BMC Gastroenterol 2013; 13:100; PMID:23758634; https://doi.org/10.1186/1471-230X-13-100
30. Maruo T, Sakamoto M, Ito C, Toda T, Benno Y. Adlercreutzia equolifaciens gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella. Int J Syst Evol Microbiol 2008; 58:1221-7; PMID:18450717; https://doi.org/10.1099/ijs.0.65404-0
31. Schogor AL, Huws SA, Santos GT, Scollan ND, Hauck BD, Winters AL, Kim EJ, Petit HV. Ruminal Prevotella spp. may play an important role in the conversion of plant lignans into human health beneficial antioxidants. PLoS One 2014; 9:e87949; PMID:24709940; https://doi.org/10.1371/journal. pone.0087949
32. Tsuchihashi R, Sakamoto S, Kodera M, Nohara T, Kinjo J. Microbial metabolism of soy isoflavones by human intestinal bacterial strains. J Nat Med 2008; 62:456-60; PMID:18648905; https://doi.org/10.1007/s11418-008-0271-y
33. Spence RD, Voskuhl RR. Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Front Neuroendocrinol 2012; 33:105-15; PMID:22209870; https://doi.org/10.1016/j.yfrne.2011.12.001
34. Schirmer M, Smeekens SP, Vlamakis H, Jaeger M, Oosting M, Franzosa EA, Horst RT, Jansen T, Jacobs L, Bonder MJ, et al. Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity. Cell 2016; 167:1897; PMID:27984736; https://doi.org/10.1016/j.cell.2016.11.046
35. Crost EH, Tailford LE, Le Gall G, Fons M, Henrissat B, Juge N. Utilisation of mucin glycans by the human gut symbiont Ruminococcus gnavus is strain-dependent. PLoS One 2013; 8:e76341; PMID:24204617; https://doi.org/10.1371/journal.pone.0076341
36. Hughes LE, Smith PA, Bonell S, Natt RS, Wilson C, Rashid T, Amor S, Thompson EJ, Croker J, Ebringer A. Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein inmultiple sclerosis. JNeuroimmunol 2003; 144:105-15; PMID:14597104; https://doi.org/10.1016/S0165-5728(03)00274-1
37. Qiao Y, Sun J, Xie Z, Shi Y, Le G. Propensity to high-fat dietinduced obesity in mice is associated with the indigenous opportunistic bacteria on the interior of Peyer’s patches. J Clin Biochem Nutr 2014; 55:120-8; PMID:25320459; https://doi.org/10.3164/jcbn.14-38